'The ultimate goal of the Cancer Origins Group is to understand why cancer starts'
Dr William Hill established the Cancer Origins Group here at our Cancer Research UK Manchester Institute in 2025. His ambition lies in understanding the specific pathways through which lung cancer emerges, and how environmental exposure like air pollution can promote disease.
The renewable energy company, ScottishPower is now committing £690,000 through Cancer Research UK, to co-fund progress towards this ambition with the University of Manchester until 2029! This is incredible recognition and support for our work, but what makes it necessary, and what are we looking to achieve?
What does air pollution have to do with cancer, and why does it matter for disease prevention?
Recent landmark papers co-authored by Dr William Hill through the Cancer Research UK and ScottishPower funded TOPICAL study, have shown how air pollutants can promote cancer via targetable inflammation, and demonstrated 14 protein signals that can predict lung cancer as much as 5 years before diagnosis.
While smoking remains the major cause of lung cancer, every 5 out of 100 cases in England each year occur in patients who have never smoked, and so it’s crucial that we understand all the mechanisms through which lung cancer arises.
Despite understanding more than ever before about lung cancer risk from air pollution and how we can identify worst affected individuals, we understand relatively little about the molecular changes that take place in our lungs for cancer to emerge. Unlocking this knowledge might be key to future innovations that treat or even prevent lung cancer entirely.
Support for patient-benefitting research
Understanding exactly how exposure to air pollution causes dormant mutant cells to awaken means investigating these changes at a molecular level.
For the Cancer Origins team, this means using a ‘lung in a dish’ preclinical model to study the specific effects of air pollutants on individual cells or tissue contexts. Multi-omic experiments will allow them to examine pollutant influence on everything from gene expression to protein synthesis, hopefully identifying markers that we can use to spot cells on the path to becoming cancerous, and even molecular pathways that might become the target of future cancer treatments.
Support from ScottishPower and the University of Manchester is allowing us to push the boundaries of our knowledge in this important area of research, and drive new discoveries for patient benefit.
Research like this is vital to understanding why lung cancer develops, even in people who have never smoked.
Thanks to long-term partners like ScottishPower, we can continue to fund world-class scientists like Dr William Hill and his team as they work to uncover new ways to prevent, detect and treat this disease, helping us to bring about a world where everybody lives longer, better lives, free from the fear of cancer.
Michelle Mitchell
CEO, Cancer Research UK



